Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

HKG:2591 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.08	0.01	0.07
Quick Ratio	3.36	5.82	1.94
Current Ratio	3.55	6.07	2.66
Return on Equity (ROE)	-	-23.27%	-
Return on Assets (ROA)	-	-11.61%	-
Return on Invested Capital (ROIC)	-	-15.20%	-
Return on Capital Employed (ROCE)	-33.70%	-23.80%	-100.30%
Buyback Yield / Dilution	-	-9.63%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.